Research a compound stack end to end — a structured protocol scaffold, how VialTalk researchers actually combine these compounds, receptor conflicts, and live COA-verified prices. Add 1–5 compounds.
Research signals
Redundancy, true conflicts, and dangerous additive effects
Review advised
No documented conflicts — some notes to review
Receptor activity map
| Receptor | L-Carnitine | GHK-Cu | 5-Amino-1MQ | MOTS-c |
|---|---|---|---|---|
| CPT shuttle / mitochondrial carnitine-acylcarnitine translocase (SLC25A20) | ||||
| NNMT (nicotinamide N-methyltransferase) | ||||
| AMPK pathway | ||||
| FOXO / PGC-1α / atrogene axis | ||||
| Copper-dependent enzymatic / ECM gene expression (collagen, glycosaminoglycan synthesis, MMP modulation) | ||||
| NFκB / TGF-β / IL-6 inflammatory signaling |
A structured, research-grounded protocol for this stack
Sign in to build a structured research protocol scaffold for L-Carnitine + GHK-Cu + 5-Amino-1MQ + MOTS-c — phases, per-compound parameters, endpoints and washout, grounded in documented research.
What VialTalk researchers actually run
No researchers have logged this exact combination yet — yours could be the first.
Researchers are also adding
Best price for each compound today
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.